Why Darling (DAR) Could Beat Earnings Estimates Again
Darling (DAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DAR - Darling Ingredients Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$64.86
DETAILS
HIGH:
$75.00
LOW:
$57.00
MEDIAN:
$64.00
CONSENSUS:
$64.86
UPSIDE:
2.14%
Stock News
Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results
IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) announced today that it will host a conference call on Thursday, July 30, 2026, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss second quarter 2026 financial results, which will be released earlier that day, and provide an update on company operations. A presentation with accompanying supplemental financial data will also be available at darlingii.com/investors. To access the call as a listener, please register for the.
Do Options Traders Know Something About Darling Ingredients Stock We Don't?
Investors need to pay close attention to DAR stock based on the movements in the options market lately.
4 Value Stocks to Buy Amid Costly AI Bets and Inflation
DAR, GPRE, TX and NEXA screen as high-earnings-yield value picks as inflation worries and AI spending fears sharpen stock selection.
4 Stocks to Buy as Online Grocery Sales Surge Amid Inflationary Woes
Online grocery sales jumped 19% in Q1 2026, putting TSN, CHEF, DAR and MAMA in focus amid rising grocery spending and high inflation.
Darling Ingredients' Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation
IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) and its health brand Rousselot today announced that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. US12636339 for Nextida GC, a first-of-its-kind collagen peptide ingredient developed to help support healthy after-meal blood sugar levels, naturally. The patent protects both the production process and the use of Nextida GC as a dietary supplement ingredient, offering a non-pharmaceutical option for managing.
Nevada’s Only Refinery Just Got a Jet-Fuel Makeover Plan
WOODS CROSS, Utah, June 02, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary - The U. S. refining map is getting smaller. West Coast capacity has been shrinking as older plants close, the major refiners spent the first quarter of 2026 emphasizing discipline over expansion, and the Trump administration has used Defense Production Act determinations to flag domestic refining as a strategic priority.
Darling Ingredients vs. Tyson Foods: Which Stock Stands Out?
DAR and TSN showcase contrasting food industry models as sustainability, protein demand and operational execution shape growth paths.
Darling Ingredients: The Recovery Is Visible
Darling Ingredients (DAR) is rated Buy, supported by a visible earnings recovery, improved margins, and a compelling forward valuation versus peers. Q1 2026 delivered sharply higher EBITDA ($406.8M), gross margin expansion to 26.1%, and a return to profitability, signaling the roughest period is likely over. Core Feed and Food Ingredients segments drove margin and EBITDA gains without major volume growth, while DGD's Q1 result was boosted by a non-recurring inventory benefit.
Is Darling Ingredients Entering a New Strategic Growth Phase?
DAR shifts focus toward cash flow, operational efficiency and balance-sheet flexibility as renewable fuels conditions improve.
Darling Ingredients Benefiting From Rising Health Food Demand Trends?
DAR is benefiting from rising demand for collagen products and expanding its focus on specialty nutrition ingredients.
Does Darling (DAR) Have the Potential to Rally 25.15% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Darling (DAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Are Consumer Staples Stocks Lagging Darling Ingredients (DAR) This Year?
Here is how Darling Ingredients (DAR) and Fomento Economico (FMX) have performed compared to their sector so far this year.
Earnings Estimates Moving Higher for Darling (DAR): Time to Buy?
Darling Ingredients (DAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Darling Ingredients Inc. (DAR) Presents at 21st Annual Global Farm to Market Conference Transcript
Darling Ingredients Inc. (DAR) Presents at 21st Annual Global Farm to Market Conference Transcript
Darling Ingredients Up 84.3% in 6 Months: What's Driving the Stock?
DAR stock has surged 84% in six months as renewable diesel margins recover, earnings rebound and operational momentum strengthens.
Darling Ingredients Signals Q2 Upside, Renewable Diesel Boost at Investor Day
Darling Ingredients NYSE: DAR used its 2026 Investor Day at the New York Stock Exchange to outline a stronger operating outlook, renewed confidence in its renewable diesel joint venture and a capital allocation plan focused first on debt reduction and then on broader shareholder-return options.
Darling Ingredients Inc. (DAR) Analyst/Investor Day Transcript
Darling Ingredients Inc. (DAR) Analyst/Investor Day Transcript
Darling Ingredients Renewable Diesel Momentum: How Durable Is it?
DAR sees improving momentum as renewable diesel demand, regulatory clarity and stronger fat pricing support key business segments.
Darling Ingredients Investors Back All Proposals at Annual Meeting
Darling Ingredients NYSE: DAR stockholders approved all proposals presented at the company's 2026 Annual Meeting of Stockholders, including the election of directors, ratification of the company's auditor, an advisory vote on executive compensation and approval of the 2026 Omnibus Incentive Plan.
Price Targets
Darling Ingredients price target raised to $62 from $58 at Barclays
$62.00
(was $56.58)
Theresa Chen
·
Barclays
Darling Ingredients initiated with an Equal Weight at Barclays
$58.00
(was $53.68)
Barclays
Darling Ingredients price target raised to $75 from $73 at Jefferies
$75.00
(was $63.77)
Jefferies
Darling Ingredients price target raised to $70 from $65 at Stephens
$70.00
(was $59.09)
Pooran Sharma
·
Stephens
Darling Ingredients price target raised to $73 from $66 at Jefferies
$73.00
(was $61.81)
Jefferies
Darling Ingredients price target raised to $61 from $45 at Scotiabank
$61.00
(was $50.77)
Scotiabank
Darling Ingredients price target raised to $64 from $62 at Baird
$64.00
(was $51.66)
Robert W. Baird
Darling Ingredients price target raised to $57 from $45 at BMO Capital
$57.00
(was $50.31)
BMO Capital
Darling Ingredients price target raised to $65 from $49 at Piper Sandler
$65.00
(was $50.31)
Piper Sandler
Darling Ingredients price target raised to $66 from $50 at Jefferies
$66.00
(was $50.31)
Dushyant Ailani
·
Jefferies
Darling Ingredients upgraded to Outperform from Neutral at Baird
$62.00
(was $45.66)
Robert W. Baird
Darling Ingredients (DAR) PT Raised to $50 at Jefferies
$50.00
(was $39.08)
Lloyd Byrne
·
Jefferies
Darling Ingredients price target raised to $50 from $45 at BofA
$50.00
(was $32.38)
UBS
UBS Reiterates Buy Rating on Darling Ingredients (DAR)
$58.00
(was $34.54)
Manav Gupta
·
UBS
Darling Ingredients price target lowered to $42 from $46 at Jefferies
$42.00
(was $31.54)
Dushyant Ailani
·
Jefferies
Darling Ingredients price target lowered to $44 from $46 at Jefferies
$44.00
(was $30.93)
Dushyant Ailani
·
Jefferies
Darling Ingredients (DAR) PT Lowered to $48 at Piper Sandler
$48.00
(was $36.86)
Ryan Todd
·
Piper Sandler
Baird Reiterates Outperform Rating on Darling Ingredients (DAR)
$60.00
(was $39.22)
Ben Kallo
·
Robert W. Baird
Darling Ingredients (DAR) PT Raised to $55 at BMO Capital
$55.00
(was $39.16)
Andrew Strelzik
·
BMO Capital
Darling Ingredients price target lowered to $47 from $53 at Jefferies
$47.00
(was $39.58)
Dushyant Ailani
·
Jefferies